NIH-funded research NIH-funded research

Understanding immune responses in autoimmune diseases like lupus and type 1 diabetes

Official title: IMMUNE EPITOPE AND ANALYSIS PROGRAM: Autoimmune diseases, including SLE, rheumatoid arthritis, type 1 diabetes, multiple sclerosis, and myathenia gravis

Funded at La Jolla Institute for Immunology · NIH-10021128 · Data updated 2026-11-12

This study is all about gathering helpful information on how our immune system works with autoimmune diseases like lupus and rheumatoid arthritis, so that patients can get better treatments and a clearer understanding of their health.

More Diabetes research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionLa Jolla Institute for Immunology
NIH-funded
Lab location1 site (La Jolla, United States)
Project startDecember 15, 2018
Project endDecember 14, 2025
Funding year2019
Award (this year)$304,459
NIH project number75N93019C00001-0-9999-3
Project IDNIH-10021128 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include individuals diagnosed with autoimmune diseases such as lupus, rheumatoid arthritis, type 1 diabetes, multiple sclerosis, or myasthenia gravis.

Less likely to help

Patients with non-autoimmune conditions or those not diagnosed with the specified autoimmune diseases may not benefit from this research.

What this research studies

This research focuses on the Immune Epitope Database and Analysis Program, which compiles detailed information about antibodies and T cell epitopes related to autoimmune diseases such as lupus, rheumatoid arthritis, type 1 diabetes, multiple sclerosis, and myasthenia gravis. It utilizes a vast collection of over 20,500 references to provide insights into how the immune system interacts with these diseases. Patients can benefit from the tools developed to predict and visualize epitopes, which may lead to better-targeted therapies and improved understanding of their conditions.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for autoimmune diseases by identifying specific immune responses.

How similar studies have gone: Previous research has shown success in utilizing epitope mapping and analysis tools to enhance understanding and treatment of autoimmune diseases.

Where this research is happening

  • La Jolla Institute for Immunology
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Sette, Alessandro — La Jolla Institute for Immunology
  • Study coordinator: Sette, Alessandro

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.